Phytopharm PLC
13Patents
5Active
13Granted
38Portfolio score
Filing activity: Nov 19, 1997 → Apr 21, 2008 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6258386A | Smilagenin and its use | Physics | 15 | Expired |
| US7589123B2 | Chemical compounds | Emerging Cross-Sectional Technologies | 7 | Active |
| US6114389A | Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions | Human Necessities | 7 | Expired |
| US6488967B1 | Gastric acid secretion | Human Necessities | 5 | Expired |
| US7033616B2 | Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use | Human Necessities | 3 | Expired |
| US6812213B2 | Steroidal sapogenins and their derivatives for treating alzheimer's disease | Physics | 3 | Expired |
| US7138427B2 | 5-β-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia | Chemistry; Metallurgy | 3 | Expired |
| US6808723B2 | Gastric acid secretion | Human Necessities | 1 | Expired |
| US7807204B2 | Processes for production of Hoodia plant extracts containing steroidal glycosides | Human Necessities | 1 | Active |
| US7923435B2 | Hoodia plant extract with improved flavor | Human Necessities | 0 | Active |
| US7507720B2 | 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia | Chemistry; Metallurgy | 0 | Active |
| US7718792B2 | Stereospecific reduction of sapogen-3-ones | Chemistry; Metallurgy | 0 | Expired |
| US7368137B2 | Smilagenin and its use | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.